
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Latigo Biotherapeutics (NASDAQ:LTGO) through any online brokerage.
Other companies in Latigo Biotherapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Latigo Biotherapeutics has a consensus price target of $45.33.
The stock price for Latigo Biotherapeutics (NASDAQ: LTGO) is $23.45 last updated September 2, 2026 at 8:53 AM EDT.
There are no upcoming dividends for Latigo Biotherapeutics.
Latigo Biotherapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Latigo Biotherapeutics.
Latigo Biotherapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.